Pfizer halts China vaccine sales as import license expires but still plans Prevnar 13 launch

April 2, 2015 2:44 PM

2 0

Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.

The world's second-biggest drugmaker by revenue said that it stopped sales immediately, a decision that affected about 200 of Pfizer's 9,000 employees in China. Pfizer said the jobs for those employees will be eliminated, but they will be encouraged to seek other work with the company in China.

Also read: MOVES-Morgan Stanley taps Nilton David as Brazil trading head -sources

Read more

To category page